About the Authors

David R. Nelson

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

nelson_david_r@lilly.com

Affiliation Eli Lilly and Company, Indianapolis, IN, United States of America

Jacqueline Brown

Roles Conceptualization, Investigation, Methodology, Project administration, Resources, Supervision, Visualization, Writing – original draft, Writing – review & editing

Affiliation Eli Lilly and Company, Bracknell, Surrey, United Kingdom

Aki Morikawa

Roles Investigation, Supervision, Writing – original draft, Writing – review & editing

Affiliation Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States of America

Michael Method

Roles Conceptualization, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

Affiliation Eli Lilly and Company, Indianapolis, IN, United States of America

Competing Interests

The authors have read the journal’s policy and report the following conflicts: David Nelson and Jacqueline Brown are employees of a commercial company: Eli Lilly and Company. They are also minor shareholders of a commercial company: Eli Lilly and Company. Michael Method is a former employee of a commercial company: Eli Lilly and Company. Michael Method is a current employee of a commercial company: Immunogen. Aki Morikawa is an employee of the University of Michigan. Aki Morikawa reports receiving institutional research funding from the following commercial companies: Eli Lilly and Company, Seattle Genetics, Eisai/H3B, Novartis, Takeda, Pfizer, and Molecular Templates Inc.; she also reports consulting with Eli Lilly and Company and serving on an advisory board for Seattle Genetics. This does not alter our adherence to PLOS ONE policies on sharing data and materials.